Intercure Ltd. Logo

Intercure Ltd.

INCR | TA

Overview

Corporate Details

ISIN(s):
IL0011063760
LEI:
549300KI5ESXF8F5GP06
Country:
Israel
Address:
11 USSISHKIN STREET, 3844346 HADERA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Intercure Ltd. is a pharmaceutical company operating in the medical cannabis sector, primarily through its wholly-owned subsidiary, Canndoc. The company's activities span the entire value chain, including research, cultivation, production, and distribution of pharmaceutical-grade, Good Manufacturing Practices (GMP) certified medical cannabis products. Intercure focuses on providing cannabis-based solutions for patients and positions itself as a leading cannabis company outside of North America.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Intercure Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-05-02 16:15
Foreign Filer Report
Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue…
English 203.6 KB
2025-05-02 16:15
Foreign Filer Report
Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue…
English 36.2 KB
2025-05-01 16:08
Foreign Filer Report
FORM 20-F
English 1.9 MB
2025-05-01 16:08
Foreign Filer Report
FORM 20-F
English 36.3 KB
2025-02-13 09:09
Foreign Filer Report
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak
English 147.7 KB
2025-02-13 09:09
Foreign Filer Report
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak
English 36.3 KB
2025-02-04 00:14
Foreign Filer Report
Results of an Extraordinary General Meeting held on February 3, 2025
English 120.2 KB
2025-02-04 00:14
Foreign Filer Report
Results of an Extraordinary General Meeting held on February 3, 2025
English 36.3 KB
2025-02-02 09:30
Pre-Annual General Meeting Information
A meeting to be held on February 3, 2025-Amendment regarding the private placem…
English 215.3 KB
2025-02-02 09:30
Foreign Filer Report
A meeting to be held on February 3, 2025-Amendment regarding the private placem…
English 36.3 KB
2025-01-28 00:20
Foreign Filer Report
The Extraordinary General Meeting was adjourned to February 3, 2025 due to lack…
English 121.9 KB
2025-01-28 00:20
Foreign Filer Report
The Extraordinary General Meeting was adjourned to February 3, 2025 due to lack…
English 36.2 KB
2024-12-31 00:54
Foreign Filer Report
Results of an Annual General Meeting of Shareholders held On December 30, 2024
English 119.9 KB
2024-12-31 00:54
Foreign Filer Report
Results of an Annual General Meeting of Shareholders held On December 30, 2024
English 36.2 KB
2024-12-22 08:14
Pre-Annual General Meeting Information
EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JANUARY 27, 2025
English 213.5 KB

Automate Your Workflow. Get a real-time feed of all Intercure Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Intercure Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK